Spondyloarthritis & psoriatic arthritis
Rising overweight and obesity in Swiss psoriatic arthritis patients, 2007-2022: a nationwide registry-population comparison
Authors' conclusion
Overweight and obesity affect nearly two-thirds of Swiss PsA patients and have increased since 2007.
Study context
- Population
- Adults with PsA in the Swiss Clinical Quality Management in Rheumatic Diseases (SCQM) registry, 2007–2022, vs the general Swiss populationPsA patients in 2022
- Participants
- 1,150 adults
- Exposure
- PsA patients vs Swiss general population
- PsAn = 1,150
- Outcome
- Overweight and obesity prevalence
- Follow-up
- 2007–2022
Methodological detailsnationwide registry-population comparison, age-, sex- and education-stratified comparison with Swiss Health Survey data
- Nationwide registry-population comparison
- Age-, sex- and education-stratified comparison with Swiss Health Survey data
Main finding
As reported in the abstract
2022
Overweight
Obese
Observational data: associations, not effects.
Further findings
Obesity prevalence over time in PsA · 2007 to 2022
- Obesity prevalence in 2007
- 19.4%
- Obesity prevalence in 2022
- 28.2%
- Trend driven by men
Clinical correlates of obesity in PsA (obese vs non-obese, cross-sectional)
- Elevated CRP, obese vs comparator
- 55.8% vs. 37.0%
- Patient global assessment, mean [SD]
- 3.2 [2.4] vs. 2.8 [2.2]
- Physician global assessment, mean [SD]
- 2.5 [2.0] vs. 2.1 [1.8]
- EQ-5D-3L health state, mean [SD]
- 0.7 [0.2] vs. 0.8 [0.2]
Obesity by educational stratum
- Varied across educational strata without a monotonic social gradient; within each stratum markedly more common in PsA than in the Swiss general population
Original publication
Rising overweight and obesity in Swiss psoriatic arthritis patients, 2007-2022: a nationwide registry-population comparison. Clin Exp Rheumatol. Published 27 February 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →